Reports
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States
Americas
Future Market Insights, Inc.
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States
MEA
Future Market Insights
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom
Asia Pacific
Future Market Insights
IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India
Respiratory devices, in the light of combination therapies for the treatment of COPD and asthma, have made significant strides toward market growth. The recent COVID pandemic has also brought in front of healthcare professionals, the significance of respiratory devices as major tools for mitigating the spread and severity of respiratory illnesses. This is set to take the market valuation to an astounding US$ 26873.7 million in 2024.
Medicare advancements, thanks to the hefty investments by private as well as public healthcare companies have also amplified the acceptance and adoption of these devices in the developed and developing parts of the world. As the industry analysis exhibits an outstanding growth of 9.90% CAGR through 2034, the future prospects of the respiratory device market seem very lucrative.
Manufacturers involved in the production and distribution of these devices are also curating equipment that is not only effective but also affordable to the general populace. Despite the advent of alternative methodologies and treatments, the market valuation is very likely to surpass US$ 69,072.5 million by the end of 2034. Medical inclusion policies and initiatives by governments in underdeveloped and developing countries are also bringing an enormous number of people under the purview of the respiratory device market.
Attributes | Details |
---|---|
Market Value for 2024 | US$ 26,873.7 million |
Projected Market Value for 2034 | US$ 69,072.5 million |
Value-based CAGR of the Market for 2024 to 2034 | 9.90% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Scientific breakthroughs in the healthcare sector, thanks to the industry-academia collaboration have led to the development of various respiratory aids. The growth rates of the respiratory pathogen testing kit market and the respiratory measurement device market, along with their opportunities and restraints have been jotted down below.
Drawing from these analytics, it can be inferred that the respiratory device industry has great potential in the future.
Respiratory Device Market:
Attributes | Respiratory Device Market |
---|---|
Value-based CAGR (2024 to 2034) | 9.90% |
Projected Market Value (2024) | US$ 26,873.7 million |
Growth Factor | The key causes propelling the market's expansion include the rising incidence of respiratory disorders such as chronic obstructive pulmonary disease (COPD), asthma, and tuberculosis. |
Restraint | There is still a section of medical professionals who are reluctant to transition towards modern and sophisticated respiratory devices as they are complex and expensive. |
Opportunity | Apart from the rising prevalence of COPD, increasing healthcare expenditure around the world will also be expected to expand market growth |
Respiratory Pathogen Testing Kit Market:
Attributes | Respiratory Pathogen Testing Kit Market |
---|---|
Value-based CAGR (2024 to 2034) | 6.10% |
Growth Factor | Diagnostic tests have undergone tremendous technological advancement in recent years, which has improved the reliability and accuracy of the identification of respiratory pathogens |
Restraint | The high cost of operating molecular processes (especially by private laboratories) restricts market expansion in emerging nations, even though molecular diagnostic methods have grown to be a significant component of life science research. |
Opportunity | The market is subject to adjustments based on legislative requirements, product adoption rates, and industry and macro dynamics. |
Respiratory Measurement Device Market:
Attributes | Respiratory Measurement Device Market |
---|---|
Value-based CAGR (2024 to 2034) | 5.1% |
Growth Factor | Increase in prevalence of sleep apnea, rise in geriatric population, and increase in demand for non-invasive and painless tests |
Restraint | Just like respiratory devices, cost remains the largest hurdle in the adoption of respiratory measurement devices as well. |
Trends | The market for respiratory monitoring devices is always expanding with new technologies improving patient comfort and increasing monitoring accuracy. |
Various types of respiratory devices have flooded the market, thanks to the advent of numerous companies in the market. Home oxygen concentrators, portable oxygen devices, positive airway pressure devices, etc., are some of the prominent ones. Among these, positive airway pressure devices are estimated to hold a market share of 31.30% in 2024.
Attributes | Details |
---|---|
Product | Positive Airway Pressure Devices |
Market Share (2024) | 31.30% |
Respiratory devices find their applications in a wide spectrum of healthcare facilities such as hospitals, ambulatory surgical centers, clinics, long-term care centers, etc. Hospitals to take the largest share of 40.70% of the overall market in 2024.
Attributes | Details |
---|---|
End User | Hospitals |
Market Share (2024) | 40.70% |
Countries | CAGR (2024 to 2034) |
---|---|
Germany | 12.10% |
France | 11.90% |
India | 11.40% |
Canada | 10.30% |
Mexico | 10.10% |
The market in Germany is a promising one. It is slated to surge at a CAGR of 12.10% through 2034.
France is also one of the most lucrative countries in this market. It is very likely to rise at a CAGR of 11.90%.
The future of the market in India also looks very bright. The market is slated to progress at a CAGR of 11.40% through 2034.
Canada’s respiratory device market is slated to inflate at a CAGR of 10.30% from 2024 to 2034.
The respiratory aid market in Mexico is also very likely to flourish in the coming years. It is slated to inflate at a CAGR of 10.10% through 2034.
The market, globally, is a well-established one with a multitude of companies vying for international dominance. Hospitals, ambulatory surgical centers, clinics, etc., heavily rely on these companies for their respiratory requirements. These companies are also pouring billions of dollars into the development of product offerings that are not only effective but also affordable for the general populace.
Recent Developments
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The market is expected to be worth US$ 26,873.7 million in 2024.
The respiratory device market is expected to reach US$ 69,072.5 million by 2034.
The market is set to develop at a CAGR of 9.90% from 2024 to 2034.
Massimo Corporation, Teleflex Incorporated, Fisher & Paykel Healthcare Limited, ResMed Inc., Hamilton Medical AG, Medtronic plc, and Koninklijke Philips N.V., are some of the major players in the market.
The market valuation in 2023 was US$ 24,623 million.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Product Life Cycle Analysis 3.5. Supply Chain Analysis 3.5.1. Supply Side Participants and their Roles 3.5.1.1. Manufacturer 3.5.2. Value Added and Value Created at Node in the Supply Chain 3.5.3. List of Raw Material Suppliers 3.5.4. List of Existing and Potential Buyer’s 3.6. Investment Feasibility Matrix 3.7. Value Chain Analysis 3.7.1. Profit Margin Analysis 3.8. PESTLE and Porter’s Analysis 3.9. Regulatory Landscape 3.9.1. By Key Regions 3.9.2. By Key Countries 3.10. Regional Parent Market Outlook 3.11. Production and Consumption Statistics 3.12. Import and Export Statistics 4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034 4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2019 to 2023 4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2024 to 2034 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Product, 2019 to 2023 5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Product, 2024 to 2034 5.3.1. Respiratory Consumables 5.3.1.1. Respiratory Mask 5.3.1.2. Nasal Cannulas 5.3.1.3. Oxygen Tubing Sets 5.3.1.4. Breathing Filters 5.3.2. Oxygen Concentrators 5.3.2.1. Home Oxygen Concentrators 5.3.2.2. Portable Oxygen 5.3.2.3. Concentrators` 5.3.2.4. Positive Airway Pressure (PAP) Devices 5.3.2.5. Polysomnography Devices 5.3.2.6. Ambulatory PSG Devices 5.3.2.7. Clinical PSG Devices 5.3.2.8. Pulse Oximeters 5.3.2.9. Mechanical Ventilators 5.3.2.10. Spirometers 5.3.3. Nebulizers 5.3.3.1. Compressed Jet Nebulizers 5.3.3.2. Ultrasonic Nebulizers 5.4. Y-o-Y Growth Trend Analysis By Product, 2019 to 2023 5.5. Absolute $ Opportunity Analysis By Product, 2024 to 2034 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End Users 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End Users, 2019 to 2023 6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End Users, 2024 to 2034 6.3.1. Hospitals 6.3.2. Ambulatory Surgical Centers 6.3.3. Clinics 6.3.4. Long Term Care Centers 6.3.5. Others 6.4. Y-o-Y Growth Trend Analysis By End Users, 2019 to 2023 6.5. Absolute $ Opportunity Analysis By End Users, 2024 to 2034 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region 7.1. Introduction 7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2019 to 2023 7.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2024 to 2034 7.3.1. North America 7.3.2. Latin America 7.3.3. Western Europe 7.3.4. Eastern Europe 7.3.5. South Asia and Pacific 7.3.6. East Asia 7.3.7. Middle East and Africa 7.4. Market Attractiveness Analysis By Region 8. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 8.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 8.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 8.2.1. By Country 8.2.1.1. USA 8.2.1.2. Canada 8.2.2. By Product 8.2.3. By End Users 8.3. Market Attractiveness Analysis 8.3.1. By Country 8.3.2. By Product 8.3.3. By End Users 8.4. Key Takeaways 9. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 9.2.1. By Country 9.2.1.1. Brazil 9.2.1.2. Mexico 9.2.1.3. Rest of Latin America 9.2.2. By Product 9.2.3. By End Users 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Product 9.3.3. By End Users 9.4. Key Takeaways 10. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 10.2.1. By Country 10.2.1.1. Germany 10.2.1.2. UK 10.2.1.3. France 10.2.1.4. Spain 10.2.1.5. Italy 10.2.1.6. Rest of Western Europe 10.2.2. By Product 10.2.3. By End Users 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Product 10.3.3. By End Users 10.4. Key Takeaways 11. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 11.2.1. By Country 11.2.1.1. Poland 11.2.1.2. Russia 11.2.1.3. Czech Republic 11.2.1.4. Romania 11.2.1.5. Rest of Eastern Europe 11.2.2. By Product 11.2.3. By End Users 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Product 11.3.3. By End Users 11.4. Key Takeaways 12. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 12.2.1. By Country 12.2.1.1. India 12.2.1.2. Bangladesh 12.2.1.3. Australia 12.2.1.4. New Zealand 12.2.1.5. Rest of South Asia and Pacific 12.2.2. By Product 12.2.3. By End Users 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Product 12.3.3. By End Users 12.4. Key Takeaways 13. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 13.2.1. By Country 13.2.1.1. China 13.2.1.2. Japan 13.2.1.3. South Korea 13.2.2. By Product 13.2.3. By End Users 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Product 13.3.3. By End Users 13.4. Key Takeaways 14. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 14.2.1. By Country 14.2.1.1. GCC Countries 14.2.1.2. South Africa 14.2.1.3. Israel 14.2.1.4. Rest of MEA 14.2.2. By Product 14.2.3. By End Users 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Product 14.3.3. By End Users 14.4. Key Takeaways 15. Key Countries Market Analysis 15.1. USA 15.1.1. Pricing Analysis 15.1.2. Market Share Analysis, 2023 15.1.2.1. By Product 15.1.2.2. By End Users 15.2. Canada 15.2.1. Pricing Analysis 15.2.2. Market Share Analysis, 2023 15.2.2.1. By Product 15.2.2.2. By End Users 15.3. Brazil 15.3.1. Pricing Analysis 15.3.2. Market Share Analysis, 2023 15.3.2.1. By Product 15.3.2.2. By End Users 15.4. Mexico 15.4.1. Pricing Analysis 15.4.2. Market Share Analysis, 2023 15.4.2.1. By Product 15.4.2.2. By End Users 15.5. Germany 15.5.1. Pricing Analysis 15.5.2. Market Share Analysis, 2023 15.5.2.1. By Product 15.5.2.2. By End Users 15.6. UK 15.6.1. Pricing Analysis 15.6.2. Market Share Analysis, 2023 15.6.2.1. By Product 15.6.2.2. By End Users 15.7. France 15.7.1. Pricing Analysis 15.7.2. Market Share Analysis, 2023 15.7.2.1. By Product 15.7.2.2. By End Users 15.8. Spain 15.8.1. Pricing Analysis 15.8.2. Market Share Analysis, 2023 15.8.2.1. By Product 15.8.2.2. By End Users 15.9. Italy 15.9.1. Pricing Analysis 15.9.2. Market Share Analysis, 2023 15.9.2.1. By Product 15.9.2.2. By End Users 15.10. Poland 15.10.1. Pricing Analysis 15.10.2. Market Share Analysis, 2023 15.10.2.1. By Product 15.10.2.2. By End Users 15.11. Russia 15.11.1. Pricing Analysis 15.11.2. Market Share Analysis, 2023 15.11.2.1. By Product 15.11.2.2. By End Users 15.12. Czech Republic 15.12.1. Pricing Analysis 15.12.2. Market Share Analysis, 2023 15.12.2.1. By Product 15.12.2.2. By End Users 15.13. Romania 15.13.1. Pricing Analysis 15.13.2. Market Share Analysis, 2023 15.13.2.1. By Product 15.13.2.2. By End Users 15.14. India 15.14.1. Pricing Analysis 15.14.2. Market Share Analysis, 2023 15.14.2.1. By Product 15.14.2.2. By End Users 15.15. Bangladesh 15.15.1. Pricing Analysis 15.15.2. Market Share Analysis, 2023 15.15.2.1. By Product 15.15.2.2. By End Users 15.16. Australia 15.16.1. Pricing Analysis 15.16.2. Market Share Analysis, 2023 15.16.2.1. By Product 15.16.2.2. By End Users 15.17. New Zealand 15.17.1. Pricing Analysis 15.17.2. Market Share Analysis, 2023 15.17.2.1. By Product 15.17.2.2. By End Users 15.18. China 15.18.1. Pricing Analysis 15.18.2. Market Share Analysis, 2023 15.18.2.1. By Product 15.18.2.2. By End Users 15.19. Japan 15.19.1. Pricing Analysis 15.19.2. Market Share Analysis, 2023 15.19.2.1. By Product 15.19.2.2. By End Users 15.20. South Korea 15.20.1. Pricing Analysis 15.20.2. Market Share Analysis, 2023 15.20.2.1. By Product 15.20.2.2. By End Users 15.21. GCC Countries 15.21.1. Pricing Analysis 15.21.2. Market Share Analysis, 2023 15.21.2.1. By Product 15.21.2.2. By End Users 15.22. South Africa 15.22.1. Pricing Analysis 15.22.2. Market Share Analysis, 2023 15.22.2.1. By Product 15.22.2.2. By End Users 15.23. Israel 15.23.1. Pricing Analysis 15.23.2. Market Share Analysis, 2023 15.23.2.1. By Product 15.23.2.2. By End Users 16. Market Structure Analysis 16.1. Competition Dashboard 16.2. Competition Benchmarking 16.3. Market Share Analysis of Top Players 16.3.1. By Regional 16.3.2. By Product 16.3.3. By End Users 17. Competition Analysis 17.1. Competition Deep Dive 17.1.1. Massimo Corporation 17.1.1.1. Overview 17.1.1.2. Product Portfolio 17.1.1.3. Profitability by Market Segments 17.1.1.4. Sales Footprint 17.1.1.5. Strategy Overview 17.1.1.5.1. Marketing Strategy 17.1.1.5.2. Product Strategy 17.1.1.5.3. Channel Strategy 17.1.2. Teleflex Incorporated 17.1.2.1. Overview 17.1.2.2. Product Portfolio 17.1.2.3. Profitability by Market Segments 17.1.2.4. Sales Footprint 17.1.2.5. Strategy Overview 17.1.2.5.1. Marketing Strategy 17.1.2.5.2. Product Strategy 17.1.2.5.3. Channel Strategy 17.1.3. Fisher & Paykel Healthcare Limited 17.1.3.1. Overview 17.1.3.2. Product Portfolio 17.1.3.3. Profitability by Market Segments 17.1.3.4. Sales Footprint 17.1.3.5. Strategy Overview 17.1.3.5.1. Marketing Strategy 17.1.3.5.2. Product Strategy 17.1.3.5.3. Channel Strategy 17.1.4. ResMed Inc. 17.1.4.1. Overview 17.1.4.2. Product Portfolio 17.1.4.3. Profitability by Market Segments 17.1.4.4. Sales Footprint 17.1.4.5. Strategy Overview 17.1.4.5.1. Marketing Strategy 17.1.4.5.2. Product Strategy 17.1.4.5.3. Channel Strategy 17.1.5. Hamilton Medical AG 17.1.5.1. Overview 17.1.5.2. Product Portfolio 17.1.5.3. Profitability by Market Segments 17.1.5.4. Sales Footprint 17.1.5.5. Strategy Overview 17.1.5.5.1. Marketing Strategy 17.1.5.5.2. Product Strategy 17.1.5.5.3. Channel Strategy 17.1.6. Medtronic plc. 17.1.6.1. Overview 17.1.6.2. Product Portfolio 17.1.6.3. Profitability by Market Segments 17.1.6.4. Sales Footprint 17.1.6.5. Strategy Overview 17.1.6.5.1. Marketing Strategy 17.1.6.5.2. Product Strategy 17.1.6.5.3. Channel Strategy 17.1.7. Koninklijke Philips N.V. 17.1.7.1. Overview 17.1.7.2. Product Portfolio 17.1.7.3. Profitability by Market Segments 17.1.7.4. Sales Footprint 17.1.7.5. Strategy Overview 17.1.7.5.1. Marketing Strategy 17.1.7.5.2. Product Strategy 17.1.7.5.3. Channel Strategy 17.1.8. Smith’s Medical 17.1.8.1. Overview 17.1.8.2. Product Portfolio 17.1.8.3. Profitability by Market Segments 17.1.8.4. Sales Footprint 17.1.8.5. Strategy Overview 17.1.8.5.1. Marketing Strategy 17.1.8.5.2. Product Strategy 17.1.8.5.3. Channel Strategy 17.1.9. General Electric Healthcare Limited 17.1.9.1. Overview 17.1.9.2. Product Portfolio 17.1.9.3. Profitability by Market Segments 17.1.9.4. Sales Footprint 17.1.9.5. Strategy Overview 17.1.9.5.1. Marketing Strategy 17.1.9.5.2. Product Strategy 17.1.9.5.3. Channel Strategy 17.1.10. Drägerwerk AG & Co. KGaA 17.1.10.1. Overview 17.1.10.2. Product Portfolio 17.1.10.3. Profitability by Market Segments 17.1.10.4. Sales Footprint 17.1.10.5. Strategy Overview 17.1.10.5.1. Marketing Strategy 17.1.10.5.2. Product Strategy 17.1.10.5.3. Channel Strategy 17.1.11. Inogen Inc. 17.1.11.1. Overview 17.1.11.2. Product Portfolio 17.1.11.3. Profitability by Market Segments 17.1.11.4. Sales Footprint 17.1.11.5. Strategy Overview 17.1.11.5.1. Marketing Strategy 17.1.11.5.2. Product Strategy 17.1.11.5.3. Channel Strategy 18. Assumptions & Acronyms Used 19. Research Methodology
Recommendations
Explore Healthcare Insights
View Reports